Advertisement
Advertisement
U.S. markets open in 1 hour 55 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Zynerba Pharmaceuticals, Inc. (ZYNE)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
0.5990+0.0190 (+3.28%)
At close: 04:00PM EST
0.5617 -0.04 (-6.23%)
After hours: 07:22PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Price Crosses Moving Average

Price Crosses Moving Average

Previous Close0.5800
Open0.5846
Bid0.5617 x 1400
Ask0.5990 x 2200
Day's Range0.5701 - 0.6000
52 Week Range0.5000 - 3.5150
Volume118,924
Avg. Volume306,214
Market Cap28.191M
Beta (5Y Monthly)1.68
PE Ratio (TTM)N/A
EPS (TTM)-0.9620
Earnings DateFeb 27, 2023 - Mar 03, 2023
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est6.44
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for ZYNE

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Zynerba Pharmaceuticals, Inc.
    CARA: Raising target price to $13.00CARA THERAPEUTICS INC has an Investment Rating of HOLD; a target price of $13.000000; an Industry Subrating of High; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of High.
    Rating
    Fair Value
    Economic Moat
    2 days agoArgus Research
View more
Advertisement
Advertisement